Traditional vaccine trials rely on large sample populations and natural infection processes. A quicker, cheaper, but riskier method, called Controlled Human Infection Model studies (CHIMs), has also been in practice for some time. In CHIMs, volunteers are deliberately infected with a pathogen to study its effects or to test the efficacy of a vaccine. In this article, Aditi examines the science behind CHIMs and the ethical implications of legalising this method in India, where such trials are presently banned.
Among the COVID-19 pandemic's many consequences is its impact on students and early career researchers all over the country, who have had to face new and challenging adversities, including breaks in experimental work, having to adapt to online education modes, and uncertainty over their future careers. A panel discussion organised by the Department of Biochemistry, JSS Medical College, Mysuru, attempted to address some of these issues.
With improved strategies to fight, prevent, and treat COVID-19 being the need of the hour, many Indian institutes and universities have redirected their research activities towards meeting this challenge. Suchibrata provides a glimpse into how various researchers at one such institute, the Indian Institute of Science Education and Research (IISER) Pune, are contributing to this effort through innovative research solutions.
The nationwide lockdown, imposed to slow the spread of the novel coronavirus, brought the work of several professionals across the country to a grinding halt, and scientists were no exception. From creating emergency glycerol stocks and shifting meetings online to dedicating themselves wholeheartedly to the pandemic efforts, here is a look at how researchers across India have dealt with this unprecedented situation.
With the COVID-19 pandemic causing massive disruptions in our healthcare system, many Indian innovators are rising to the challenge. In this article, Vanshika explores some new technologies and ingenious solutions developed by Indian researchers from academia as well as industry that are currently in the pipeline.